ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Alzamend Neuro, Inc.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 10, 2026
$1.33+0.03 (+2.31%)
Close on Oct 19, 2026
- Market cap
- $5.96M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jul 22, 2025(first seen in filings) | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| May 12, 2025 | 1-for-9 reverse | Earlier per-share figures multiplied by 9 |
| Jul 30, 2024(first seen in filings) | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jul 16, 2024 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Dec 15, 2023(first seen in filings) | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |
| Oct 31, 2023 | 1-for-15 reverse | Earlier per-share figures multiplied by 15 |